Miami, FL, United States of America

Sergio C Veulens


Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Hematology: The Contributions of Sergio C Veulens

Introduction

Sergio C Veulens is a notable inventor based in Miami, FL, who has made significant contributions to the field of hematology. With a focus on developing innovative lytic reagents, he has been instrumental in advancing methods for the differential determination of leukocytes in blood. His work has led to the filing of two patents that enhance the accuracy and efficiency of blood analysis.

Latest Patents

Sergio's latest patents include a reagent and method for the differential determination of leukocytes in blood. This invention provides a lytic reagent composition that selectively lyses red blood cells in a blood sample. The system enables the differentiation of at least two subpopulations of leukocytes and is designed to maintain the cellular morphology of the leukocytes. This method can be applied to analyze both normal and abnormal blood samples, as well as samples from non-human animals. Another patent focuses on a lytic reagent that allows for the automatic determination of leukocyte subpopulations, utilizing a combination of reagents to achieve a five-part differential of leukocytes.

Career Highlights

Sergio C Veulens is associated with Coulter International Corporation, where he has contributed to the development of innovative medical technologies. His expertise in reagent formulation and blood analysis has positioned him as a key figure in the field.

Collaborations

Sergio has collaborated with notable colleagues such as Yi Li and Carole Jo Young, enhancing the research and development efforts at Coulter International Corporation.

Conclusion

Sergio C Veulens is a pioneering inventor whose work in the development of lytic reagents has significantly impacted the field of hematology. His patents reflect a commitment to improving blood analysis techniques, ultimately benefiting medical diagnostics and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…